Product
CDK 4/6 inhibitors
1 clinical trial
4 indications
Indication
Breast CancerIndication
Quality of LifeIndication
ToxicityIndication
Older PatientsClinical trial
Implementing Geriatric Assessment for Dose Optimization of CDK 4/6-inhibitors in Older Breast Cancer Patients - a Pragmatic Randomized-controlled Trial (IMPORTANT Trial)Status: Recruiting, Estimated PCD: 2028-04-01